US 4,031,097 AGranted

Descarboxylysergic acid

AssigneeEli Lilly and Company

InventorsNicholas J. Bach, David A. Hall, Edmund C. Kornfeld

Life of this patent

Estimating the term…

Abstract

Descarboxylysergic acid prepared from 2,3-dihydro-8.beta.-hydroxy-6-methyl-9-ergolene or from penniclavine has oxytocic, serotonin antagonist, prolactin inhibition and muscle contracting activities.

Claims3

Dependent claims

Descarboxylysergic acid.

Dependencies are inferred from the claim text.

Facts

Application: 05/628,306Filed 3 Nov 1975 · division
Priority: 17 Aug 1973
Granted: 21 Jun 1977
Term ends: Not estimatedThe source records don’t support an estimate.

Classification3 codes

C07D 457/02
Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: [IMAGE…: with…
C07D 457/10
Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: [IMAGE…: with hetero…
C07D
Heterocyclic compounds

Family

Serial389,281Parent of this continuation-in-part · filed 17 Aug 1973
Serial504,395Parent of this division · filed 9 Sep 1974
US 3,954,772 AParent of this division
US 4,031,097 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…